Johnson & Johnson Announces EC Approval of Agreement to Supply 200 Million Doses of Janssen’s COVID-19 Vaccine Candidate
Johnson & Johnson announced the EC, acting on behalf of the European Union (EU) Member States, has approved an Advance...
Johnson & Johnson announced the EC, acting on behalf of the European Union (EU) Member States, has approved an Advance...
Pfizer Inc. and Sangamo Therapeutics, Inc., a genomic medicines company, announced that the first participant has been dosed in the...
Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival...
Novavax, Inc. , a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that it has initiated...
Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate,...
The first batch of Russia’s coronavirus vaccine Sputnik V has entered “civil circulation”, reports from state media claimed on Thursday....
Clinical research, forensic and anti-doping toxicology laboratories facing the challenges of analyzing increasing numbers of analytes in biological matrices, can...
Messe Düsseldorf Asia announced that the 13th edition of MEDICAL FAIR ASIA will take place as a digital edition from...
CPhI Annual Report – launched ahead of the first CPhI Festival of Pharma (5-16 October, 2020), the world’s largest digital...
Boehringer Ingelheim and Mirati Therapeutics, Inc. entered a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor,...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.